ISCO
International Stem Cell Corp

21
Loading...
Loading...
International Stem Cell Corp. operates as a research and development company for the therapeutic market. It focuses on advancing potential clinical applications of human parthenogenetic stem cells for the treatment of various diseases of the central nervous system and liver diseases. The firm operates through three segments: Therapeutic Market, Biomedical Market and Anti-Aging Market. The Biomedical Market segment markets and sells primary human cell research products with two product categories, cells and media. The Anti-Aging market segment markets and sells a line of skincare products sold through two sales channels: ecommerce and professional. The ecommerce channel sells direct to customers through online orders, while professional sales are to spas, salons and other skincare providers. The Therapeutic Market segment focuses on the research and development of human parthenogenetic stem cells for the treatment of diseases of the central nervous system, liver diseases and is currently conducting clinical trials for the treatment of Parkinson's disease. The company was founded by William B. Adams, Kenneth C. Aldrich and Gregory S. Keller in June 2005 and is headquartered in San Diego, CA.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
32

Frequently Asked Questions

What is Market Cap of International Stem Cell Corporation?
What is the 52-week high for International Stem Cell Corporation?
What is the 52-week low for International Stem Cell Corporation?
What is International Stem Cell Corporation stock price today?
What was International Stem Cell Corporation stock price yesterday?
What is the PE ratio of International Stem Cell Corporation?
What is the Price-to-Book ratio of International Stem Cell Corporation?
What is the 50-day moving average of International Stem Cell Corporation?
How many employess does International Stem Cell Corporation has?

Latest ISCO News

View
No ISCO news at the moment.

Advertisement|Remove ads.

Advertisement|Remove ads.